gadolinium has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 12 (66.67) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (5.56) | 2.80 |
Authors | Studies |
---|---|
Aylwin, SJB; Dimitriadis, GK; Epure, A; Kaltsas, G; Leca, BM; Mytilinaiou, M; Randeva, HS; Tsoli, M | 1 |
Gurwell, JA | 1 |
Bonneville, F; Bonneville, JF; Cattin, F | 1 |
Bahuleyan, B; Easwer, HV; Krishna, K; Menon, G; Nair, S; Rao, BR | 1 |
Daousi, C; Deepak, D; Javadpour, M; MacFarlane, IA | 1 |
Fretz, C; Haertel, M; Zaunbauer, W | 1 |
D'Haens, J; Luypaert, R; Osteaux, M; Stadnik, T | 1 |
Ardaens, Y; Clarisse, J; Delecourt, F; Dewailly, D; Fossati, P; Leclerc, X; Pruvo, JP | 1 |
Clarisse, J; Dewailly, D; Fossati, P; Hamon-Kérautret, M; Leclerc, X; Pruvo, JP | 1 |
d'Haens, J; Luypaert, R; Osteaux, M; Spruyt, D; Stadnik, T; van Binst, A | 1 |
Bishop, JE; George, S; Keller, MA; Kucharczyk, W; Plewes, DB | 1 |
Bakke, SJ; Hald, JK; Nakstad, PH; Skalpe, IO | 1 |
Brue, T; Chabert-Orsini, V; Cortesi, L; Girard, N; Jaquet, P; Maman, P; Raybaud, C | 2 |
Frezza, F; Longo, R; Magnaldi, S; Pozzi-Mucelli, RS; Razavi, IS; Ukmar, M | 1 |
Ceroni, AM; Ceroni, L; Di Biasi, C; Gualdi, GF; Melone, A; Pingi, A; Polettini, E; Trasimeni, G | 1 |
Beckers, A; Buisseret, T; Luypaert, R; Osteaux, M; Stadnik, T; Stevenaert, A | 1 |
Bittner, RC; Felix, R; Nakamura, T; Schörner, W | 1 |
1 review(s) available for gadolinium and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
[Magnetic resonance tomography of hypophyseal tumors].
Topics: Adenoma; Adult; Aged; Diagnosis, Differential; Empty Sella Syndrome; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1995 |
3 trial(s) available for gadolinium and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis.
Topics: Adult; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies | 2021 |
Detection of pituitary microadenomas: comparison of dynamic keyhole fast spin-echo, unenhanced, and conventional contrast-enhanced MR imaging.
Topics: Adenoma; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1994 |
MR imaging of pituitary region lesions with gadodiamide injection.
Topics: Adenoma; Adult; Aged; Contrast Media; Craniopharyngioma; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Pituitary Diseases; Pituitary Neoplasms; Prolactinoma; Retrospective Studies | 1994 |
14 other study(ies) available for gadolinium and Adenoma, Prolactin-Secreting, Pituitary
Article | Year |
---|---|
Case of the month. Prolactinoma.
Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Prolactin; Prolactinoma; Radionuclide Imaging | 2008 |
[Imaging of pituitary adenomas].
Topics: Adenoma; Adult; Contrast Media; Female; Follow-Up Studies; Gadolinium; Hemorrhage; Humans; Hyperpituitarism; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm, Residual; Patient Care Planning; Pituitary Neoplasms; Prolactinoma; Sex Factors; Young Adult | 2009 |
Non-surgical management of cystic prolactinomas.
Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Gadolinium; Hormones; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult | 2009 |
Macroprolactinomas and epilepsy.
Topics: Adult; Anticonvulsants; Dopamine Agonists; Drug Therapy, Combination; Epilepsy; Epilepsy, Temporal Lobe; Female; Gadolinium; Humans; Magnetic Resonance Imaging, Interventional; Male; Middle Aged; Phenytoin; Pituitary Neoplasms; Prevalence; Prolactinoma; Statistics, Nonparametric; Treatment Outcome | 2007 |
The value of three-dimensional turbo-FLASH and spin-echo sequences in the detection of pituitary microadenomas following gadolinium administration.
Topics: Adenoma; Adrenocorticotropic Hormone; Contrast Media; Gadolinium; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma; Sensitivity and Specificity | 1994 |
[Searching for prolactin microadenoma: scanner or MRI?].
Topics: Adolescent; Adult; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed | 1993 |
Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa.
Topics: Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Contrast Media; Female; Gadolinium; Hemorrhage; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Sella Turcica | 1994 |
Pituitary microadenomas: diagnosis with dynamic serial CT, conventional CT and T1-weighted MR imaging before and after injection of gadolinium.
Topics: Adenoma; Adrenocorticotropic Hormone; Artifacts; Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Observer Variation; Pituitary Gland; Pituitary Neoplasms; Probability; Prolactinoma; Prospective Studies; Sella Turcica; Sensitivity and Specificity; Single-Blind Method; Tomography, X-Ray Computed | 1994 |
Evaluation of three-dimensional MRI exploration of prolactin-secreting microadenomas.
Topics: Adolescent; Adult; Arachnoid; Bromocriptine; Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 1993 |
Assessment of pituitary microadenomas: comparison between 2D and 3D MR sequences.
Topics: Adult; Aged; Artifacts; Contrast Media; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Humans; Hyperprolactinemia; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Phobic Disorders; Pituitary Neoplasms; Prolactinoma; Prospective Studies; Time Factors | 1997 |
[A comparison between computed tomography and magnetic resonance in the verification of prolactinomas].
Topics: Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Gadolinium; Gadolinium DTPA; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Prolactinoma; Tomography, X-Ray Computed | 1992 |
[Evaluation of nuclear magnetic resonance imaging in tridimensional acquisition in the investigation of prolactin microadenoma].
Topics: Adolescent; Adult; Bromocriptine; Female; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Pituitary Neoplasms; Prolactinoma | 1992 |
Pituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium.
Topics: Adenoma; Adrenocorticotropic Hormone; Contrast Media; Gadolinium; Growth Hormone; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Predictive Value of Tests; Prolactinoma; Sensitivity and Specificity | 1990 |
The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.
Topics: Adenoma; Contrast Media; Gadolinium; Gadolinium DTPA; Growth Hormone; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Pentetic Acid; Pituitary Neoplasms; Prolactinoma | 1988 |